Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Wen An

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Annals of Translational Medicine|November 22, 2016
Time to progression ratio: promising new metric or just another metric?Ming-Wen An, Sumithra J Mandrekar
Biology Direct|April 19, 2015
Test on existence of histology subtype-specific prognostic signatures among early stage lung adenocarcinoma and squamous cell carcinoma patients using a Cox-model based filterSuyan Tian, Chi Wang, Ming-Wen An
Computational Statistics & Data Analysis|July 17, 2008
Flexible Random Intercept Models for Binary Outcomes Using Mixtures of NormalsBrian Caffo, Ming-Wen An, Charles Rohde
JAMA Network Open|August 1, 2020
Reopening Colleges During the Coronavirus Disease 2019 (COVID-19) Pandemic-One Size Does Not Fit AllElizabeth H Bradley, Ming-Wen An, Ellen Fox
Statistics in Medicine|January 11, 2014
Choosing profile double-sampling designs for survival estimation with application to President's Emergency Plan for AIDS Relief evaluationMing-Wen An, Constantine E Frangakis, Constantin T Yiannoutsos
Contemporary Clinical Trials|May 14, 2013
A review of phase II trial designs for initial marker validationSumithra J Mandrekar, Ming-Wen An, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2013
Application of tumor measurement-based metrics in the real worldMing-Wen An, Sumithra J Mandrekar, Daniel J Sargent
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2012
A 2-stage phase II design with direct assignment option in stage II for initial marker validationMing-Wen An, Sumithra J Mandrekar, Daniel J Sargent
Cancer Letters|March 19, 2016
Precision oncology: A new era of cancer clinical trialsLindsay A Renfro, Ming-Wen An, Sumithra J Mandrekar
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 18, 2020
Principles of Good Clinical Trial DesignMing-Wen An, Quyen Duong, Jennifer Le-Rademacher, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Annals of Translational Medicine|November 22, 2016
Time to progression ratio: promising new metric or just another metric?Ming-Wen An, Sumithra J Mandrekar
Biology Direct|April 19, 2015
Test on existence of histology subtype-specific prognostic signatures among early stage lung adenocarcinoma and squamous cell carcinoma patients using a Cox-model based filterSuyan Tian, Chi Wang, Ming-Wen An
Computational Statistics & Data Analysis|July 17, 2008
Flexible Random Intercept Models for Binary Outcomes Using Mixtures of NormalsBrian Caffo, Ming-Wen An, Charles Rohde
JAMA Network Open|August 1, 2020
Reopening Colleges During the Coronavirus Disease 2019 (COVID-19) Pandemic-One Size Does Not Fit AllElizabeth H Bradley, Ming-Wen An, Ellen Fox
Statistics in Medicine|January 11, 2014
Choosing profile double-sampling designs for survival estimation with application to President's Emergency Plan for AIDS Relief evaluationMing-Wen An, Constantine E Frangakis, Constantin T Yiannoutsos
Contemporary Clinical Trials|May 14, 2013
A review of phase II trial designs for initial marker validationSumithra J Mandrekar, Ming-Wen An, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2013
Application of tumor measurement-based metrics in the real worldMing-Wen An, Sumithra J Mandrekar, Daniel J Sargent
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2012
A 2-stage phase II design with direct assignment option in stage II for initial marker validationMing-Wen An, Sumithra J Mandrekar, Daniel J Sargent
Cancer Letters|March 19, 2016
Precision oncology: A new era of cancer clinical trialsLindsay A Renfro, Ming-Wen An, Sumithra J Mandrekar
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 18, 2020
Principles of Good Clinical Trial DesignMing-Wen An, Quyen Duong, Jennifer Le-Rademacher, et al.
Pageof 3